Products Portfolio
Finished Pharmaceutical Products / Formulations
1- Cardiovascular
2- Oncology
3- Diabetes & Endocrinology
4- Anti-Infectives
5- Neurology & Psychiatry
6- Gastroenterology
7- Respiratory
8- Nephrology & Transplantation
9- Women’s Health
10- Pediatrics
11- Critical Care
12- Custom Sourcing of Finished Pharmaceutical Formulations Upon Client
Requirements
Products Portfolio
Vaccines & Biopharmaceuticals
1- Human Vaccines
2- Biosimilars
3- Monoclonal Antibodies
4- Blood & Plasma-Derived Products
Products Portfolio
Active Pharmaceutical Ingredients (APIs)
1- General APIs
2- Oncology APIs
3- Anti-Infective APIs
4- Cardiovascular APIs
5- Endocrinology APIs
6- Hormonal & Peptide APIs
7- High Potency APIs (HPAPIs)
Products Portfolio
Pharmaceutical Intermediates
1- Generic Drug Intermediates
2- Oncology Intermediates
3- Specialty Intermediates
4- Custom Synthesis Intermediates
Products Portfolio
Key Therapeutic Areas
• Oncology
• Targeted therapies, monoclonal antibodies, chemotherapy
• Immunology & Transplantation
• Tacrolimus, Mycophenolate, Biologics
• Diabetes & Endocrinology
• Insulins, Hormonal therapies
• Cardiovascular
• Hypertension, Lipid management, Anticoagulants
• Infectious Diseases
• Antibiotics, Antivirals, Vaccines
• Neurology
• CNS therapies, Rare neurological diseases
• Rare Diseases
• Orphan medicines and specialty products
• Critical Care
• ICU and emergency medicines
Marcpharma Products
| Product Availability & Supply Solutions
MARC PHARMA provides access to:
1. Registered and unregistered medicines (subject to local regulations)
2. Shortage medicines
3. Hospital and institutional requirements
4. Emergency medicines
5. Rare disease treatments
6. Clinical trial comparators
7. Special import requests
Marcpharma Services
| BUSINESS COOPERATION MODEL
We as MARC PHARMA welcome partnerships with:
• Pharmaceutical distributors
• Importers
• Government procurement agencies
• Hospital groups
• Contract manufacturing partners
Available models:
1. Distribution agreements
2. Supply contracts
3. Licensing opportunities
4. Market entry partnerships